FUSION PHARMACEUTICALS INC - COM (FUSN)

CUSIP: 36118A100

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / COM
Total 13F shares
69,088,929
Share change
+8,285,869
Total reported value
$1,472,970,461
Put/Call ratio
272%
Price per share
$21.32
Number of holders
114
Value change
+$304,054,766
Number of buys
89
Number of sells
41

Quarterly Holders Quick Answers

What is CUSIP 36118A100?
CUSIP 36118A100 identifies FUSN - FUSION PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FUSION PHARMACEUTICALS INC - COM (FUSN) as of Q1 2024

As of 31 Mar 2024, FUSION PHARMACEUTICALS INC - COM (FUSN) was held by 114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 69,088,929 shares. The largest 10 holders included FEDERATED HERMES, INC., PERCEPTIVE ADVISORS LLC, Avidity Partners Management LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), FIL Ltd, Pentwater Capital Management LP, JOHNSON & JOHNSON, CANADA PENSION PLAN INVESTMENT BOARD, TPG GP A, LLC, and FMR LLC. This page lists 114 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.